Skip to content

S-Ketamine in preventing persistent post-surgical pain following repeat cesarean section in anxious women with scarred uterus

S-Ketamine in preventing persistent post-surgical pain following repeat cesarean section in anxious women with scarred uterus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118128
Enrollment
Unknown
Registered
2026-02-02
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Post-surgical Pain (PPSP)

Interventions

Control group:After fetal delivery, the parturient received an intravenous infusion of 20 mL of normal saline over a duration of 20 minutes. Postoperatively, the patient was administered patient-contr
S-ketamine group:After fetal delivery, the parturient received an intravenous infusion of 20 mL of S-ketamine 0.25mg/kg over a duration of 20 minutes. Postoperatively, the patient was administered pat

Sponsors

Women' Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Preoperative anxiety (GAD-7 score >= 7); (2) Age 20-45 years; (3) Women with scarred uterus; (4) Body Mass Index <= 40 kg/m^2; (5) undergo repeat cesarean section.

Exclusion criteria

Exclusion criteria: (1) Patients who have used opioids or other sedative analgesics within one week; (2) Patients allergic to the active ingredient or any excipients of this product; (3) Patients at serious risk of elevated blood pressure or intracranial pressure; (4) Pregnant women with preeclampsia or eclampsia. (5) Patients with severe cardiac, pulmonary, hepatic, or renal dysfunction.

Design outcomes

Primary

MeasureTime frame
Incidence of PPSP ;

Secondary

MeasureTime frame
Pain scores;Effective pain relief rate;The consumption of opioid drugs;Recovery quality assessment;Postpartum depress assessment;Maternal and neonatal bonding assessment;

Countries

China

Contacts

Public ContactXia Fan

Women' Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital

xiafan54@163.com+86 137 7061 6851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026